Arcturus Therapeutics to Present at Two Investor Conferences in March
February 19, 2020 07:30 ET
|
Arcturus Therapeutics Holdings Inc.
SAN DIEGO, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (the “Company”, NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery, development and...
Arcturus Therapeutics Appoints Steve Hughes, M.D., as Chief Development Officer
January 08, 2020 07:00 ET
|
Arcturus Therapeutics Holdings Inc.
SAN DIEGO, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (the “Company”, NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery, development and...
Arcturus Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update
November 07, 2019 16:01 ET
|
Arcturus Therapeutics Holdings Inc.
SAN DIEGO, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (“Arcturus Therapeutics”) (NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery,...
Arcturus Therapeutics Expands Platform with STARR Technology™
November 07, 2019 07:30 ET
|
Arcturus Therapeutics Holdings Inc.
SAN DIEGO, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (NASDAQ: ARCT, the “Company”), a leading messenger RNA medicines company focused on the discovery, development and...
Arcturus Therapeutics to Report Corporate Overview and Financial Results on November 7th
November 04, 2019 07:30 ET
|
Arcturus Therapeutics Holdings Inc.
SAN DIEGO, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery, development and commercialization of...
Arcturus Therapeutics to Present at Three Upcoming Investor Conferences
October 02, 2019 09:00 ET
|
Arcturus Therapeutics Holdings Inc.
SAN DIEGO, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (“Arcturus Therapeutics”) (NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery,...
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
September 26, 2019 08:00 ET
|
Arcturus Therapeutics Holdings Ltd
SAN DIEGO, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (“Arcturus” or the “Company”), a leading RNA medicines company focused on the discovery, development and commercialization of mRNA...
Arcturus Therapeutics Announces Appointment of Dr. Edward Holmes M.D. and Re-Appointment of Andy Sassine to the Board of Directors
September 23, 2019 08:00 ET
|
Arcturus Therapeutics Holdings Ltd
SAN DIEGO, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (“Arcturus Therapeutics”) (NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery,...
Arcturus Therapeutics To Present at Two Investor Conferences in September
August 26, 2019 08:00 ET
|
Arcturus Therapeutics Holdings Ltd
SAN DIEGO, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (“Arcturus Therapeutics”) (NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery,...
Arcturus Therapeutics Announces Second Quarter Financial Results and Provides a Corporate Update
August 15, 2019 08:00 ET
|
Arcturus Therapeutics Holdings Ltd
Ultragenyx Pharmaceutical, Inc. expands collaboration, becoming Arcturus’ largest shareholderCystic Fibrosis Foundation increases commitment to $15 millionArcturus receives Orphan Drug Designation...